(Q34164734)

31 July 2017

title

Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population (English)

1 reference

31 July 2017

0 references

Lacticaseibacillus casei

1 reference

3

Eiji Ishikawa

1 reference

31 July 2017

1

Takafumi Sakai

1 reference

31 July 2017

Hiroshi Makino

2

1 reference

31 July 2017

Kenji Oishi

series ordinal

4

1 reference

31 July 2017

Akira Kushiro

series ordinal

5

1 reference

31 July 2017

publication date

15 February 2011

1 reference

International Journal of Food Sciences and Nutrition

31 July 2017

published in

1 reference

31 July 2017

volume

62

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

423-430

1 reference

An extended assessment of bowel habits in a general population

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

A placebo-controlled trial of prucalopride for severe chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

How well does stool form reflect colonic transit?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Stool form scale as a useful guide to intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Review article: self-report measures to evaluate constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Epidemiology of constipation in Europe and Oceania: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Intestinal transit time in the population calculated from self made observations of defecation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09637486.2010.542408

10.3109/09637486.2010.542408

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference